US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins: Shanghai Thursday, January 9, 2025, 1 ...

Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams: Our Bureau, Bengaluru Thursday, January 9, 2025, 15:30 Hrs [IST] Eli Lilly an ...

Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...

US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...

Our Bureau, New Delhi Wednesday, January 8, 2025, 09:00 Hrs [IST] Medical Technology Association of India (MTaI), which repr ...

Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...

Harsh Vaish: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] Mergers and Acquisitions (M&As) have ...

Of course, safety and security in hospitals have been a matter of great concern in the country. There have been reports of intermittent violence against the medical fraternity by the relatives of the ...

Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...

Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary: Our Bureau, Mumbai Tuesday, January 7, 2025, 17:15 Hrs [IST] Zydus L ...

JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...

Our Bureau, Mumbai Tuesday, January 7, 2025, 16:45 Hrs [IST] ...